Transform the patient experience
with carpal tunnel release using ultrasound guidance.
Carpal tunnel syndrome (CTS) affects an estimated 12 million Americans causing pain and keeping people from work and the activities they love. More than 6 million1 have been recommended for surgery, yet there are only 650,0002 procedures performed every year. With 2.1 million3 new CTS diagnoses annually, the treatment gap continues to grow.
Traditional open and endoscopic carpal tunnel release (CTR) procedures are effective but may result in a lengthy recovery period and a large and sometimes painful scar.4,5,6
Understanding why patients elect to avoid traditional CTR surgery will help close the treatment gap.7,8
* Reasons for Declining CTR Procedures7,8
Performing CTR under the guidance of ultrasound allows physicians to perform CTR surgery through a small, less disruptive incision while providing improved visualization of all critical anatomy in the wrist and hand. Benefits include4,9,10:
The low profile SX-One MicroKnife® is an innovative surgical device that enables carpal tunnel release through a small incision (~5 mm) under the guidance of ultrasound, or with a traditional mini-open incision without ultrasound guidance. Less invasive techniques can result in a faster recovery time and minimal scarring.4,11,12
Most patients can return to work and the activities they love in just 3-6 days!4,9
That is absolutely amazing. That is paradigm shifting.
Performing carpal tunnel release (CTR) under the guidance of ultrasound was first documented in 199711,15. The SX-One MicroKnife, developed by physicians from the Mayo Clinic, was first used in a CTR procedure in February 2017 and has been used in over 6,000 procedures, including many bilateral simultaneous releases.13,14
Transforming surgeon practices through world class professional education and training.
October 1, 2020 – October 3, 2020
Industry Forum: Friday October 2nd 8:00–9:00am CDT
Demonstration of CTR with Ultrasound Guidance